SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?


To: JOHN WHITE who wrote (881)5/4/1998 12:29:00 PM
From: Getcher  Read Replies (1) | Respond to of 4650
 
Hi Thread ...

Sorry I have been unable to get to my Issues/Questions addendum post. The wife's Birthday was this weekend (Boy did I remember in the nick of time!!!) and was tied up (not literally) all weekend. I will try and get to this tonight, or latest Tuesday night. Super busy now with my month-end close at work.

Great post on the Risks John ... I had to take a break to read that one!!!!

Getcher

(22% equity stake insuates ownership of common stock usually. Preferred is more associated with a debt-type capital financing. Either way, Biomoda can dilute ADOT's interests by issuing new shares ... depends on the wording of the agreements as to whether ADOT has a non-dilutive clause. If not, Biomoda is in control of ADOT's ultimate interest in them ... extremely difficult to tell where ADOT stands without the agreements to read. However, knowing that they know each other (ADOT and Biomoda management came out of the same lab and are planning on working together on the test equipment end of the deal) provides some comfort that ADOT will reap the rewards of a fair partnership).